An AI-guided device for medics moves towards commercial use

The team behind AI-GUIDE is transferring its vascular-access prototype to AutonomUS Medical Technologies, a startup founded by staff from MIT Lincoln Laboratory and Massachusetts General Hospital. The effort has received the Federal Laboratory Consortium’s 2026 Excellence in Technology Transfer Award.

AI-GUIDE combines custom AI software with handheld ultrasound equipment to help a user place a guidewire and catheter in a blood vessel. Its developers designed it for care outside a hospital, including military medics working with limited specialist support.

A company to carry it forward

MIT’s account traces the project through prototype development and clinical testing at Massachusetts General Hospital. AutonomUS is now responsible for moving the technology towards commercial use. That gives the research a company to handle the next stages, rather than leaving it as a laboratory project.

The startup has secured FDA Breakthrough Device Designation. It has also received an Air Force small-business research grant, alongside private investment and support from other US agencies. The team is developing related technology for peripheral nerve blocks, intended for trauma care and pain management.